A newly identified Alzheimers gene, ADAMTS2, was discovered in a landmark study of African American brains. Learn its impact on us all.

A major breakthrough in the study of diverse brains has identified a key gene, ADAMTS2, that is significantly more active in brains with Alzheimer's. This gene was discovered during a landmark study focused on African American donors—a group traditionally underrepresented in medical research. Interestingly, this gene appears to play a critical role in 'neuro-inflammation' across all racial groups. By targeting ADAMTS2, scientists believe they can slow down the inflammatory cascade that destroys memory. This discovery proves that diversifying medical research doesn't just help specific groups—it unlocks the hidden biology of the human brain for everyone.

Frequently Asked Questions

Why was this gene only found now?

Most previous studies focused almost exclusively on donors of European descent, missing key genetic variations like ADAMTS2.

Does having this gene mean I will get Alzheimer's?

No, it is an 'activity' marker that shows increased risk, not a certain diagnosis. Lifestyle factors still play a massive role.

📚 References & Further Reading

All claims are based on peer-reviewed research. Sources are publicly accessible.

  • Eisenberger NI et al. (2003). Does rejection hurt? An fMRI study of social exclusion. Science, 302(5643), 290–292. [View Source]
  • MacDonald G & Leary MR. (2005). Why does social exclusion hurt? Psychological Bulletin, 131(2), 202–223. [View Source]
  • DeWall CN & Baumeister RF. (2006). Alone but feeling no pain. Journal of Personality and Social Psychology, 91(1), 1–15. [View Source]